| Activation of signal transducer and activator of transcription 3 in renal cell carcinoma: a study of incidence and its association with pathological features and clinical outcome A Horiguchi, M Oya, T Shimada, A Uchida, K Marumo, M Murai The Journal of urology 168 (2), 762-765, 2002 | 215 | 2002 |
| Increased nuclear factor-κB activation is related to the tumor development of renal cell carcinoma M Oya, A Takayanagi, A Horiguchi, R Mizuno, M Ohtsubo, K Marumo, ... Carcinogenesis 24 (3), 377-384, 2003 | 158 | 2003 |
| STAT3 inhibitor WP1066 as a novel therapeutic agent for renal cell carcinoma A Horiguchi, T Asano, K Kuroda, A Sato, J Asakuma, K Ito, M Hayakawa, ... British journal of cancer 102 (11), 1592-1599, 2010 | 142 | 2010 |
| Fatty acid synthase over expression is an indicator of tumor aggressiveness and poor prognosis in renal cell carcinoma A Horiguchi, T Asano, T Asano, K Ito, M Sumitomo, M Hayakawa The Journal of urology 180 (3), 1137-1140, 2008 | 139 | 2008 |
| 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor, fluvastatin, as a novel agent for prophylaxis of renal cancer metastasis A Horiguchi, M Sumitomo, J Asakuma, T Asano, T Asano, M Hayakawa Clinical cancer research 10 (24), 8648-8655, 2004 | 131 | 2004 |
| Akt activation in renal cell carcinoma: contribution of a decreased PTEN expression and the induction of apoptosis by an Akt inhibitor S Hara, M Oya, R Mizuno, A Horiguchi, K Marumo, M Murai Annals of oncology 16 (6), 928-933, 2005 | 128 | 2005 |
| STAT3, but not ERKs, mediates the IL-6–induced proliferation of renal cancer cells, ACHN and 769P A Horiguchi, M Oya, K Marumo, M Murai Kidney international 61 (3), 926-938, 2002 | 121 | 2002 |
| Elevated Akt activation and its impact on clinicopathological features of renal cell carcinoma A Horiguchi, M Oya, A Uchida, KEN Marumo, M Murai The Journal of urology 169 (2), 710-713, 2003 | 113 | 2003 |
| Substitution urethroplasty using oral mucosa graft for male anterior urethral stricture disease: Current topics and reviews A Horiguchi International Journal of Urology 24 (7), 493-503, 2017 | 104 | 2017 |
| Increased serum leptin levels and over expression of leptin receptors are associated with the invasion and progression of renal cell carcinoma A Horiguchi, M Sumitomo, J Asakuma, T Asano, R Zheng, T Asano, ... The Journal of urology 176 (4), 1631-1635, 2006 | 89 | 2006 |
| A pilot study of photoacoustic imaging system for improved real‐time visualization of neurovascular bundle during radical prostatectomy A Horiguchi, K Tsujita, K Irisawa, T Kasamatsu, K Hirota, M Kawaguchi, ... The Prostate 76 (3), 307-315, 2016 | 88 | 2016 |
| ZD1839 modulates paclitaxel response in renal cancer by blocking paclitaxel-induced activation of the epidermal growth factor receptor–extracellular signal-regulated kinase pathway M Sumitomo, T Asano, J Asakuma, T Asano, A Horiguchi, M Hayakawa Clinical cancer research 10 (2), 794-801, 2004 | 85 | 2004 |
| Prediction of extraprostatic cancer by prostate specific antigen density, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer A Horiguchi, J Nakashima, Y Horiguchi, K Nakagawa, M Oya, T Ohigashi, ... The Prostate 56 (1), 23-29, 2003 | 85 | 2003 |
| Novel SN-38–incorporated polymeric micelle, NK012, strongly suppresses renal cancer progression M Sumitomo, F Koizumi, T Asano, A Horiguchi, K Ito, T Asano, T Kakizoe, ... Cancer research 68 (6), 1631-1635, 2008 | 80 | 2008 |
| Pharmacological inhibitor of fatty acid synthase suppresses growth and invasiveness of renal cancer cells A Horiguchi, T Asano, T Asano, K Ito, M Sumitomo, M Hayakawa The Journal of urology 180 (2), 729-736, 2008 | 74 | 2008 |
| Decreased serum adiponectin levels in patients with metastatic renal cell carcinoma A Horiguchi, K Ito, M Sumitomo, F Kimura, T Asano, M Hayakawa Japanese journal of clinical oncology 38 (2), 106-111, 2008 | 74 | 2008 |
| Pilot study of prostate cancer angiogenesis imaging using a photoacoustic imaging system A Horiguchi, M Shinchi, A Nakamura, T Wada, K Ito, T Asano, H Shinmoto, ... Urology 108, 212-219, 2017 | 72 | 2017 |
| Impact of caveolin-1 expression on clinicopathological parameters in renal cell carcinoma A Horiguchi, T Asano, J Asakuma, T Asano, M Sumitomo, M Hayakawa The Journal of urology 172 (2), 718-722, 2004 | 63 | 2004 |
| Increased activation of CCAAT/enhancer binding protein-β correlates with the invasiveness of renal cell carcinoma M Oya, A Horiguchi, R Mizuno, K Marumo, M Murai Clinical cancer research 9 (3), 1021-1027, 2003 | 59 | 2003 |
| Do transurethral treatments increase the complexity of urethral strictures? A Horiguchi, M Shinchi, A Masunaga, K Ito, T Asano, R Azuma Journal of Urology 199 (2), 508-514, 2018 | 55 | 2018 |
